Citation Impact
Citing Papers
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
The past, present, and future of pertussis. The role of adults in epidemiology and future control.
1989
Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
2021 StandoutNobel
Neonatal bcg vaccination and mycobacterial cervical adenitis in childhood
1987
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
2010 Standout
Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants
2004
Diphtheria: Changing patterns in the developing world and the industrialized world
1995
Inactivated poliovirus vaccine: past and present experience
1996
Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice
2003
Immunological reconstitution following bone marrow transplantation
1997
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Free radicals, metals and antioxidants in oxidative stress-induced cancer
2006 Standout
Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test
1998
CampylobacterInfection in Poultry-Processing Workers, Virginia, USA, 2008–2011
2013
Immunologic correlates of protection induced by vaccination
2001
Response to Tetanus Toxoid Immunization after Allogeneic Bone Marrow Transplantation
1990
Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union
1996
Under-Reporting of Adverse Drug Reactions
2006 Standout
The Present Status of Tetanus and Tetanus Vaccination
1995
HPV vaccine: Cervarix
2010
Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study
2008
WOMEN AND HIV
1997
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
Serum Levels of Rubella Virus Antibodies Indicating Immunity: Response to Vaccination of Subjects with Low or Undetectable Antibody Concentrations
1997
Live virus immunization after orthotopic liver transplantation
2005
Immunity to diphtheria in Northern Norway and Northwestern Russia
1995
CHAT Oral Polio Vaccine Was Not the Source of Human Immunodeficiency Virus Type 1 Group M for Humans
2001
The Molecular Epidemiology of Three Biotypes of Corynebacterium diphtheriae in the Seattle Outbreak, 1972-1982
1989
Epstein‐Barr virus specific salivary antibodies as related to stress caused by examinations
2001
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype
2001
Revaccination with Measles, Tetanus, Poliovirus, Haemophilus influenzae Type B, Meningococcus C, and Pneumococcus Vaccines in Children after Hematopoietic Stem Cell Transplantation
2007
Immunological memory in humans
2004
One-year Mortality Rates of Patients Receiving Methadone and Buprenorphine Maintenance Therapy
2006
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children
2011
Resurgence of diphtheria
1995
Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients
1998
Methadone maintenance treatment: the balance between life‐saving treatment and fatal poisonings
2007
Efficacy of Low Doses of the Polyethylene Glycol Derivative of Interleukin-2 in Modulating the Immune Response of Patients with Human Immunodeficiency Virus Type 1 Infection
1993
Graft-versus-host disease
2009 Standout
Myocarditis
2011 Standout
HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action
2003 Standout
Low prevalence of diphtheria antitoxin in children and adults in northern Germany
1995
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
2011 StandoutNobel
Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden
1990
Early measles vaccination in bone marrow transplant recipients
2005
Vaccines for Transplant Recipients
2001
Mumps Outbreaks in Vaccinated Populations: Are Available Mumps Vaccines Effective Enough to Prevent Outbreaks?
2008
Rising incidence and prevalence of herpes simplex type 2 infection in a cohort of 26 year old New Zealanders
2001
The Adolescent Brain
2008 Standout
Stress-induced immune dysfunction: implications for health
2005 Standout
Human Milk and the Response of Intestinal Epithelium to Infection
2001
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
2017 Standout
Multiple Sclerosis
2000 Standout
New use of BCG for recombinant vaccines
1991 StandoutNature
Changes in Mortality, Arrests, and Hospitalizations in Nonvoluntary Treated Heroin Addicts in Relation to Methadone Treatment
1998
Thrombocytopenic Purpura after Measles-Mumps-Rubella Vaccination: A Systematic Review of the Literature and Guidance for Management
2010
Evolution of the mammary gland from the innate immune system?
2006 StandoutNobel
Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT
2005
Immunity to Poliovirus and Immunization with Inactivated Poliovirus Vaccine After Autologous Bone Marrow Transplantation
1994
The Changing Epidemiology of Diphtheria in the Vaccine Era
2000
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
The interpersonal theory of suicide.
2010 Standout
Copper in Infant Nutrition: Safety of World Health Organization Provisional Guideline Value for Copper Content of Drinking Water
1998
Indigenous health in Latin America and the Caribbean
2006 Standout
Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies
2004
Recent advances on chitosan-based micro- and nanoparticles in drug delivery
2004 Standout
Molecular epidemiology of nasopharyngeal corynebacteria in healthy adults from an area where diphtheria vaccination has been extensively practiced
1992
Unreliable mtDNA data due to nuclear insertions: a cautionary tale from analysis of humans and other great apes
2004 StandoutNobel
Contaminated polio vaccine theory refuted
2004 Nature
Inactivated Polio Vaccine (IPV): A strong candidate vaccine for achieving global polio eradication program
2009
Nontoxigenic Corynebacterium diphtheriae Isolated from Intravenous Drug Users
1994
The health and health system of South Africa: historical roots of current public health challenges
2009 Standout
Diphtheria among Alcoholic Urban Adults
1989
Molecular Epidemiology of the 1984–1986 Outbreak of Diphtheria in Sweden
1988
Efficacy and safety of immunization for pre- and post- liver transplant children
2002
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
Host Defense Benefits of Breastfeeding for the Infant
2001
Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines
1998
Food-Related Illness and Death in the United States
1999 Standout
Fatal Respiratory Disease Due to Corynebacterium diphtheriae: Case Report and Review of Guidelines for Management, Investigation, and Control
1993
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
1994 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Cutaneous response to recombinant interleukin 2 in human immunodeficiency virus 1-seropositive individuals.
1990
Analysis of a library of macaque nuclear mitochondrial sequences confirms macaque origin of divergent sequences from old oral polio vaccine samples
2002
Optimal duration of exclusive breastfeeding
2012 Standout
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2020 StandoutNobel
Review of the evidence for an association between infant feeding and childhood cancer
1998
SIDS and Other Sleep-Related Infant Deaths: Expansion of Recommendations for a Safe Infant Sleeping Environment
2011 Standout
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
2014 Standout
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Follicular Helper CD4 T Cells (TFH)
2011 Standout
Presumed BCG Infection in a Boy with Chronic Granulomatous Disease
1984
Day-to-Day Reactogenicity and the Healthy Vaccinee Effect of Measles-Mumps-Rubella Vaccination
2000
Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host
1998
Measles in bone marrow transplant recipients during an outbreak in Sao Paulo, Brazil
2002
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women
2006
A gradient of childhood self-control predicts health, wealth, and public safety
2011 Standout
ORTHOMYXOVIRAL AND PARAMYXOVIRAL INFECTIONS IN TRANSPLANT PATIENTS
1995
Zanvil Alexander Cohn 1926-1993.
1994 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Global Epidemiology of Campylobacter Infection
2015 Standout
Immunity to Campylobacter: its role in risk assessment and epidemiology
2009
Clinical microbiology of coryneform bacteria
1997 Standout
Severe Measles in Immunocompromised Patients
1992
The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas.
2004
Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation
1994
Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspecies
2005 Standout
Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction
1993
Molecular Analyses of Oral Polio Vaccine Samples
2001 StandoutScienceNobel
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Simian Immunodeficiency Virus Infection in Wild-Caught Chimpanzees from Cameroon
2004 StandoutNobel
Genetic relationships of Corynebacterium diphtheriae strains isolated from a diphtheria case and carriers by restriction fragment length polymorphism of rRNA genes
1995
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Neurotoxins Affecting Neuroexocytosis
2000 Standout
Vaccinology of poliomyelitis
1984
Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety.
1990
Correlates of Protection Induced by Vaccination
2010 Standout
Works of M Böttiger being referenced
Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: first experience.
1983
Antibody stimulation in individuals without demonstrable poliovirus antibodies following a fifth injection of inactivated polio-virus vaccine.
1973
[Epidemiology of a case of poliomyelitis].
1979
Epidemiological events surrounding a paralytic case of poliomyelitis in Sweden.
1979
Screening for HIV-1 antibodies in pregnancy: results from the Swedish national programme.
1993
Efficacy and Safety of Vaccination of Marrow Transplant Recipients with a Live Attenuated Measles, Mumps, and Rubella Vaccine
1989
Analysis of oral polio vaccine CHAT stocks
2001 Nature
Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months
1995
Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus
1994
Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination
1997
Epidemiology and Immunity to Tetanus in Sweden
1987
Immunity to tetanus, diphtheria and poliomyelitis in the adult population of Sweden in 1991
1998
The AIDS epidemic among Scandinavian women
1994
Polio immunity to killed vaccine: an 18-year follow-up
1990
Comparison of Serum and Salivary Antibodies in Children Vaccinated with Oral Live or Parenteral Inactivated Poliovirus Vaccines of Different Antigen Concentrations
1991
A Study of the Sero-immunity That Has Protected the Swedish Population against Poliomyelitis for 25 Years
1987
Isolation of Polioviruses from Sewage and their Characteristics: Experience over Two Decades in Sweden
1992
Avidity and titers of the antibody response to two inactivated poliovirus vaccines with different antigen content
1993
Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults
1994
Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme
1998
Antibody Responses to Parenteral and Oral Vaccines Are Impaired by Conventional and Low Protein Formulas as Compared to Breast‐feeding
1990
A 15-year surveillance study of antibodies to herpes simplex virus types 1 and 2 in a cohort of young girls
1992
Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment
2003
Swedish inactivated polio vaccine: Laboratory standardization and clinical experience over a 30-year period
1992
Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment
1995
Antitoxin Antibody Levels and the Outcome of Illness during an Outbreak of Diphtheria among Alcoholics
1986
ANTIBODY STIMULATION IN INDIVIDUALS WITHOUT DEMONSTRABLE POLIOVIRUS ANTIBODIES FOLLOWING A FIFTH INJECTION OF INACTIVATED POLIOVIRUS VACCINE
1973
Experiences of vaccination with inactivated poliovirus vaccine in Sweden.
1981
Theoretical and practical considerations in the application of killed poliovirus vaccine for the control of paralytic poliomyelitis.
1981
The immunizing effect and reactogenicity of two live attenuated mumps virus vaccines in Swedish schoolchildren
1983
Serological Immunity to Diphtheria in Sweden in 1978 and 1984
1986
Long-Term Immunity Following Vaccination with Killed Poliovirus Vaccine in Sweden, a Country with No Circulating Poliovirus
1984
Intradermal testing with multiple recall antigens for identification of cell-mediated immune deficiency in homosexual men
1986
An Outbreak of Campylobacter Enteritis among the Staff of a Poultry Abattoir in Sweden
1983
Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.
1987
OSTEITIS AND OTHER COMPLICATIONS CAUSED BY GENERALIZED BCG‐ITIS
1982
Vaccination with Attenuated Type l Poliovirus, the Chat Strain III. Antibody Response and Spread of Virus in Schoolchildren
1966
The elimination of polio in the Scandinavian countries.
1994
[Control of tuberculosis in Sweden--a suggestion].
1986
SERO‐IMMUNITY TO POLIOMYELITIS VIRUS IN SWEDEN 10 YEARS AFTER INTRODUCTION OF VACCINATIONS WITH INACTIVATED POLIOVIRUS VACCINE
1969